Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
About this item
Full title
Author / Creator
Hsu, En-Chi , Rice, Meghan A. , Bermudez, Abel , Marques, Fernando Jose Garcia , Aslan, Merve , Liu, Shiqin , Ghoochani, Ali , Zhang, Chiyuan Amy , Chen, Yun-Sheng , Zlitni, Aimen , Kumar, Sahil , Nolley, Rosalie , Habte, Frezghi , Shen, Michelle , Koul, Kashyap , Peehl, Donna M. , Zoubeidi, Amina , Gambhir, Sanjiv S. , Kunder, Christian A. , Pitteri, Sharon J. , Brooks, James D. and Stoyanova, Tanya
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Resistance to androgen deprivation therapy, or castration-resistant prostate cancer (CRPC), is often accompanied by metastasis and is currently the ultimate cause of prostate cancer-associated deaths in men. Recently, secondary hormonal therapies have led to an increase of neuroendocrine prostate cancer (NEPC), a highly aggressive variant of CRPC....
Alternative Titles
Full title
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
Authors, Artists and Contributors
Author / Creator
Rice, Meghan A.
Bermudez, Abel
Marques, Fernando Jose Garcia
Aslan, Merve
Liu, Shiqin
Ghoochani, Ali
Zhang, Chiyuan Amy
Chen, Yun-Sheng
Zlitni, Aimen
Kumar, Sahil
Nolley, Rosalie
Habte, Frezghi
Shen, Michelle
Koul, Kashyap
Peehl, Donna M.
Zoubeidi, Amina
Gambhir, Sanjiv S.
Kunder, Christian A.
Pitteri, Sharon J.
Brooks, James D.
Stoyanova, Tanya
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6994991
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6994991
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.1905384117
